PF-232798

Generic Name: PF-232798

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₂₉H_₄₀FN_₅O_₂

CAS Number: 849753-15-7

Unique Ingredient Identifier: 63P7W7886U

Background: PF-232798 is under investigation in clinical trial NCT01140425 (Study To Evaluate The Effect Of A Multiple Oral Dose Of PF-00232798 On QT Intervals In Healthy Subjects).

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Study To Evaluate The Effect Of A Multiple Oral Dose Of PF-00232798 On QT Intervals In Healthy Subjects

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: PF-00232798
Drug: Placebo
Drug: Moxifloxacin

First Posted Date: 2010-06-09

Last Posted Date: 2010-12-23

Lead Sponsor: Pfizer

Target Recruit Count: 44

Registration Number: NCT01140425

Locations: 🇸🇬
Pfizer Investigational Site, Singapore, Singapore

A Phase 2 Study Of PF-00232798 In HIV Positive Patients

Phase 2

Completed

Conditions: HIV

Interventions: Drug: PF-00232798

First Posted Date: 2007-07-03

Last Posted Date: 2013-10-30

Lead Sponsor: Pfizer

Target Recruit Count: 43

Registration Number: NCT00495677

Locations: 🇩🇪
Pfizer Investigational Site, Koeln, Germany

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy